Complete and durable response of pulmonary large-cell neuroendocrine carcinoma to pembrolizumab.

Naoki KadotaNobuo HatakeyamaHiroyuki HinoMichihiro KunishigeYoshihiro KondoYoshio OkanoHisanori MachidaKeishi NaruseTsutomu ShinoharaShoji SakiyamaFumitaka OgushiEiji Takeuchi

Published in: Cancer reports (Hoboken, N.J.) (2021)

Pembrolizumab may be used as a treatment option for pulmonary LCNEC.

Keyphrases

pulmonary hypertension
advanced non small cell lung cancer
single cell
cell therapy
combination therapy
epidermal growth factor receptor